Ep. 62 - The Battle Over Medicare Coverage: Should all FDA approved drugs be paid for?
Matthew and Ron dive into the debate on whether Medicare should cover every FDA-approved drug, focusing on the case of Aduhelm and Leqembi, two Alzheimer's drugs. Aduhelm was is not covered by Medicare due to limited effectiveness and high cost. The Centers for Medicare and Medicaid Services announced Leqemebi would be in certain circumstances.
Follow Matthew and Ron on X:
Matthew Handley on X
Ron Howrigon on X
Subscribe to the FLATLINING Podcast from Fulcrum Strategies to stay informed about healthcare and policy topics.
Create your
podcast in
minutes
It is Free